Kronos Longevity Research Institute Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00154180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

conjugated equine estrogens (2 trials)

estradiol (progynon depot) (2 trials)

progesterone (progestasert) (2 trials)

Drugs in Other Trials (1)

tart cherry (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteriosclerosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4